Medical Care
Global Enteric Disease Testing and Therapeutic Market Research Report 2024
- Jan 26, 24
- ID: 26882
- Pages: 74
- Figures: 142
- Views: 24
Enteric diseases are the infections caused by ingestion of contaminated food or water. These infections are commonly caused by bacteria and viruses. Poor maintenance of hygiene and sanitation, particularly due to rising population and urbanization is increasing the prevalence of enteric diseases.
The global Enteric Disease Testing and Therapeutic market was valued at US$ 3014.3 million in 2023 and is anticipated to reach US$ 3330.2 million by 2030, witnessing a CAGR of 1.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Enteric Disease Testing and Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enteric Disease Testing and Therapeutic.
Report Scope
The Enteric Disease Testing and Therapeutic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enteric Disease Testing and Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enteric Disease Testing and Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
GlaxoSmithKline
Becton Dickinson
bioMérieux
Sanofi
Bayer Pharma
Bio-Rad
Quest Diagnostics
Trinity Biotech
Segment by Type
Bacterial Disease
Viral Disease
Parasitic Disease
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Enteric Disease Testing and Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Enteric Disease Testing and Therapeutic market was valued at US$ 3014.3 million in 2023 and is anticipated to reach US$ 3330.2 million by 2030, witnessing a CAGR of 1.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Enteric Disease Testing and Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enteric Disease Testing and Therapeutic.
Report Scope
The Enteric Disease Testing and Therapeutic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enteric Disease Testing and Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enteric Disease Testing and Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
GlaxoSmithKline
Becton Dickinson
bioMérieux
Sanofi
Bayer Pharma
Bio-Rad
Quest Diagnostics
Trinity Biotech
Segment by Type
Bacterial Disease
Viral Disease
Parasitic Disease
Segment by Application
Hospital
Specialty Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Enteric Disease Testing and Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Enteric Disease Testing and Therapeutic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bacterial Disease
1.2.3 Viral Disease
1.2.4 Parasitic Disease
1.3 Market by Application
1.3.1 Global Enteric Disease Testing and Therapeutic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Enteric Disease Testing and Therapeutic Market Perspective (2019-2030)
2.2 Enteric Disease Testing and Therapeutic Growth Trends by Region
2.2.1 Global Enteric Disease Testing and Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Enteric Disease Testing and Therapeutic Historic Market Size by Region (2019-2024)
2.2.3 Enteric Disease Testing and Therapeutic Forecasted Market Size by Region (2025-2030)
2.3 Enteric Disease Testing and Therapeutic Market Dynamics
2.3.1 Enteric Disease Testing and Therapeutic Industry Trends
2.3.2 Enteric Disease Testing and Therapeutic Market Drivers
2.3.3 Enteric Disease Testing and Therapeutic Market Challenges
2.3.4 Enteric Disease Testing and Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Enteric Disease Testing and Therapeutic Players by Revenue
3.1.1 Global Top Enteric Disease Testing and Therapeutic Players by Revenue (2019-2024)
3.1.2 Global Enteric Disease Testing and Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Enteric Disease Testing and Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Enteric Disease Testing and Therapeutic Revenue
3.4 Global Enteric Disease Testing and Therapeutic Market Concentration Ratio
3.4.1 Global Enteric Disease Testing and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Enteric Disease Testing and Therapeutic Revenue in 2023
3.5 Enteric Disease Testing and Therapeutic Key Players Head office and Area Served
3.6 Key Players Enteric Disease Testing and Therapeutic Product Solution and Service
3.7 Date of Enter into Enteric Disease Testing and Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Enteric Disease Testing and Therapeutic Breakdown Data by Type
4.1 Global Enteric Disease Testing and Therapeutic Historic Market Size by Type (2019-2024)
4.2 Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Type (2025-2030)
5 Enteric Disease Testing and Therapeutic Breakdown Data by Application
5.1 Global Enteric Disease Testing and Therapeutic Historic Market Size by Application (2019-2024)
5.2 Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Enteric Disease Testing and Therapeutic Market Size (2019-2030)
6.2 North America Enteric Disease Testing and Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024)
6.4 North America Enteric Disease Testing and Therapeutic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Enteric Disease Testing and Therapeutic Market Size (2019-2030)
7.2 Europe Enteric Disease Testing and Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024)
7.4 Europe Enteric Disease Testing and Therapeutic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size (2019-2030)
8.2 Asia-Pacific Enteric Disease Testing and Therapeutic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2019-2024)
8.4 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Enteric Disease Testing and Therapeutic Market Size (2019-2030)
9.2 Latin America Enteric Disease Testing and Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024)
9.4 Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size (2019-2030)
10.2 Middle East & Africa Enteric Disease Testing and Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024)
10.4 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Enteric Disease Testing and Therapeutic Introduction
11.1.4 Abbott Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Enteric Disease Testing and Therapeutic Introduction
11.2.4 GlaxoSmithKline Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.2.5 GlaxoSmithKline Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Detail
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Enteric Disease Testing and Therapeutic Introduction
11.3.4 Becton Dickinson Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.3.5 Becton Dickinson Recent Development
11.4 bioMérieux
11.4.1 bioMérieux Company Detail
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux Enteric Disease Testing and Therapeutic Introduction
11.4.4 bioMérieux Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.4.5 bioMérieux Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Enteric Disease Testing and Therapeutic Introduction
11.5.4 Sanofi Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 Bayer Pharma
11.6.1 Bayer Pharma Company Detail
11.6.2 Bayer Pharma Business Overview
11.6.3 Bayer Pharma Enteric Disease Testing and Therapeutic Introduction
11.6.4 Bayer Pharma Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.6.5 Bayer Pharma Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Detail
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Enteric Disease Testing and Therapeutic Introduction
11.7.4 Bio-Rad Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.7.5 Bio-Rad Recent Development
11.8 Quest Diagnostics
11.8.1 Quest Diagnostics Company Detail
11.8.2 Quest Diagnostics Business Overview
11.8.3 Quest Diagnostics Enteric Disease Testing and Therapeutic Introduction
11.8.4 Quest Diagnostics Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.8.5 Quest Diagnostics Recent Development
11.9 Trinity Biotech
11.9.1 Trinity Biotech Company Detail
11.9.2 Trinity Biotech Business Overview
11.9.3 Trinity Biotech Enteric Disease Testing and Therapeutic Introduction
11.9.4 Trinity Biotech Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.9.5 Trinity Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Enteric Disease Testing and Therapeutic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bacterial Disease
1.2.3 Viral Disease
1.2.4 Parasitic Disease
1.3 Market by Application
1.3.1 Global Enteric Disease Testing and Therapeutic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Enteric Disease Testing and Therapeutic Market Perspective (2019-2030)
2.2 Enteric Disease Testing and Therapeutic Growth Trends by Region
2.2.1 Global Enteric Disease Testing and Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Enteric Disease Testing and Therapeutic Historic Market Size by Region (2019-2024)
2.2.3 Enteric Disease Testing and Therapeutic Forecasted Market Size by Region (2025-2030)
2.3 Enteric Disease Testing and Therapeutic Market Dynamics
2.3.1 Enteric Disease Testing and Therapeutic Industry Trends
2.3.2 Enteric Disease Testing and Therapeutic Market Drivers
2.3.3 Enteric Disease Testing and Therapeutic Market Challenges
2.3.4 Enteric Disease Testing and Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Enteric Disease Testing and Therapeutic Players by Revenue
3.1.1 Global Top Enteric Disease Testing and Therapeutic Players by Revenue (2019-2024)
3.1.2 Global Enteric Disease Testing and Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Enteric Disease Testing and Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Enteric Disease Testing and Therapeutic Revenue
3.4 Global Enteric Disease Testing and Therapeutic Market Concentration Ratio
3.4.1 Global Enteric Disease Testing and Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Enteric Disease Testing and Therapeutic Revenue in 2023
3.5 Enteric Disease Testing and Therapeutic Key Players Head office and Area Served
3.6 Key Players Enteric Disease Testing and Therapeutic Product Solution and Service
3.7 Date of Enter into Enteric Disease Testing and Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Enteric Disease Testing and Therapeutic Breakdown Data by Type
4.1 Global Enteric Disease Testing and Therapeutic Historic Market Size by Type (2019-2024)
4.2 Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Type (2025-2030)
5 Enteric Disease Testing and Therapeutic Breakdown Data by Application
5.1 Global Enteric Disease Testing and Therapeutic Historic Market Size by Application (2019-2024)
5.2 Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Enteric Disease Testing and Therapeutic Market Size (2019-2030)
6.2 North America Enteric Disease Testing and Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024)
6.4 North America Enteric Disease Testing and Therapeutic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Enteric Disease Testing and Therapeutic Market Size (2019-2030)
7.2 Europe Enteric Disease Testing and Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024)
7.4 Europe Enteric Disease Testing and Therapeutic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size (2019-2030)
8.2 Asia-Pacific Enteric Disease Testing and Therapeutic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2019-2024)
8.4 Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Enteric Disease Testing and Therapeutic Market Size (2019-2030)
9.2 Latin America Enteric Disease Testing and Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024)
9.4 Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size (2019-2030)
10.2 Middle East & Africa Enteric Disease Testing and Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024)
10.4 Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Enteric Disease Testing and Therapeutic Introduction
11.1.4 Abbott Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Detail
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Enteric Disease Testing and Therapeutic Introduction
11.2.4 GlaxoSmithKline Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.2.5 GlaxoSmithKline Recent Development
11.3 Becton Dickinson
11.3.1 Becton Dickinson Company Detail
11.3.2 Becton Dickinson Business Overview
11.3.3 Becton Dickinson Enteric Disease Testing and Therapeutic Introduction
11.3.4 Becton Dickinson Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.3.5 Becton Dickinson Recent Development
11.4 bioMérieux
11.4.1 bioMérieux Company Detail
11.4.2 bioMérieux Business Overview
11.4.3 bioMérieux Enteric Disease Testing and Therapeutic Introduction
11.4.4 bioMérieux Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.4.5 bioMérieux Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Enteric Disease Testing and Therapeutic Introduction
11.5.4 Sanofi Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 Bayer Pharma
11.6.1 Bayer Pharma Company Detail
11.6.2 Bayer Pharma Business Overview
11.6.3 Bayer Pharma Enteric Disease Testing and Therapeutic Introduction
11.6.4 Bayer Pharma Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.6.5 Bayer Pharma Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Detail
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Enteric Disease Testing and Therapeutic Introduction
11.7.4 Bio-Rad Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.7.5 Bio-Rad Recent Development
11.8 Quest Diagnostics
11.8.1 Quest Diagnostics Company Detail
11.8.2 Quest Diagnostics Business Overview
11.8.3 Quest Diagnostics Enteric Disease Testing and Therapeutic Introduction
11.8.4 Quest Diagnostics Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.8.5 Quest Diagnostics Recent Development
11.9 Trinity Biotech
11.9.1 Trinity Biotech Company Detail
11.9.2 Trinity Biotech Business Overview
11.9.3 Trinity Biotech Enteric Disease Testing and Therapeutic Introduction
11.9.4 Trinity Biotech Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024)
11.9.5 Trinity Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Enteric Disease Testing and Therapeutic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Bacterial Disease
Table 3. Key Players of Viral Disease
Table 4. Key Players of Parasitic Disease
Table 5. Global Enteric Disease Testing and Therapeutic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Enteric Disease Testing and Therapeutic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Enteric Disease Testing and Therapeutic Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Enteric Disease Testing and Therapeutic Market Share by Region (2019-2024)
Table 9. Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Enteric Disease Testing and Therapeutic Market Share by Region (2025-2030)
Table 11. Enteric Disease Testing and Therapeutic Market Trends
Table 12. Enteric Disease Testing and Therapeutic Market Drivers
Table 13. Enteric Disease Testing and Therapeutic Market Challenges
Table 14. Enteric Disease Testing and Therapeutic Market Restraints
Table 15. Global Enteric Disease Testing and Therapeutic Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Enteric Disease Testing and Therapeutic Market Share by Players (2019-2024)
Table 17. Global Top Enteric Disease Testing and Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enteric Disease Testing and Therapeutic as of 2023)
Table 18. Ranking of Global Top Enteric Disease Testing and Therapeutic Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Enteric Disease Testing and Therapeutic Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Enteric Disease Testing and Therapeutic Product Solution and Service
Table 22. Date of Enter into Enteric Disease Testing and Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2019-2024)
Table 26. Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2025-2030)
Table 28. Global Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2019-2024)
Table 30. Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2025-2030)
Table 32. North America Enteric Disease Testing and Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Enteric Disease Testing and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Enteric Disease Testing and Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Enteric Disease Testing and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Enteric Disease Testing and Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
Table 47. Abbott Company Detail
Table 48. Abbott Business Overview
Table 49. Abbott Enteric Disease Testing and Therapeutic Product
Table 50. Abbott Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 51. Abbott Recent Development
Table 52. GlaxoSmithKline Company Detail
Table 53. GlaxoSmithKline Business Overview
Table 54. GlaxoSmithKline Enteric Disease Testing and Therapeutic Product
Table 55. GlaxoSmithKline Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 56. GlaxoSmithKline Recent Development
Table 57. Becton Dickinson Company Detail
Table 58. Becton Dickinson Business Overview
Table 59. Becton Dickinson Enteric Disease Testing and Therapeutic Product
Table 60. Becton Dickinson Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 61. Becton Dickinson Recent Development
Table 62. bioMérieux Company Detail
Table 63. bioMérieux Business Overview
Table 64. bioMérieux Enteric Disease Testing and Therapeutic Product
Table 65. bioMérieux Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 66. bioMérieux Recent Development
Table 67. Sanofi Company Detail
Table 68. Sanofi Business Overview
Table 69. Sanofi Enteric Disease Testing and Therapeutic Product
Table 70. Sanofi Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. Bayer Pharma Company Detail
Table 73. Bayer Pharma Business Overview
Table 74. Bayer Pharma Enteric Disease Testing and Therapeutic Product
Table 75. Bayer Pharma Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 76. Bayer Pharma Recent Development
Table 77. Bio-Rad Company Detail
Table 78. Bio-Rad Business Overview
Table 79. Bio-Rad Enteric Disease Testing and Therapeutic Product
Table 80. Bio-Rad Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 81. Bio-Rad Recent Development
Table 82. Quest Diagnostics Company Detail
Table 83. Quest Diagnostics Business Overview
Table 84. Quest Diagnostics Enteric Disease Testing and Therapeutic Product
Table 85. Quest Diagnostics Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 86. Quest Diagnostics Recent Development
Table 87. Trinity Biotech Company Detail
Table 88. Trinity Biotech Business Overview
Table 89. Trinity Biotech Enteric Disease Testing and Therapeutic Product
Table 90. Trinity Biotech Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 91. Trinity Biotech Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Enteric Disease Testing and Therapeutic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Enteric Disease Testing and Therapeutic Market Share by Type: 2023 VS 2030
Figure 3. Bacterial Disease Features
Figure 4. Viral Disease Features
Figure 5. Parasitic Disease Features
Figure 6. Global Enteric Disease Testing and Therapeutic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Enteric Disease Testing and Therapeutic Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Specialty Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Enteric Disease Testing and Therapeutic Report Years Considered
Figure 12. Global Enteric Disease Testing and Therapeutic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Enteric Disease Testing and Therapeutic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Enteric Disease Testing and Therapeutic Market Share by Region: 2023 VS 2030
Figure 15. Global Enteric Disease Testing and Therapeutic Market Share by Players in 2023
Figure 16. Global Top Enteric Disease Testing and Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enteric Disease Testing and Therapeutic as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Enteric Disease Testing and Therapeutic Revenue in 2023
Figure 18. North America Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Enteric Disease Testing and Therapeutic Market Share by Country (2019-2030)
Figure 20. United States Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Enteric Disease Testing and Therapeutic Market Share by Country (2019-2030)
Figure 24. Germany Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Enteric Disease Testing and Therapeutic Market Share by Region (2019-2030)
Figure 32. China Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Enteric Disease Testing and Therapeutic Market Share by Country (2019-2030)
Figure 40. Mexico Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Enteric Disease Testing and Therapeutic Market Share by Country (2019-2030)
Figure 44. Turkey Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Abbott Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 48. Becton Dickinson Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 49. bioMérieux Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 50. Sanofi Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 51. Bayer Pharma Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 52. Bio-Rad Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 53. Quest Diagnostics Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 54. Trinity Biotech Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global Enteric Disease Testing and Therapeutic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Bacterial Disease
Table 3. Key Players of Viral Disease
Table 4. Key Players of Parasitic Disease
Table 5. Global Enteric Disease Testing and Therapeutic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Enteric Disease Testing and Therapeutic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Enteric Disease Testing and Therapeutic Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Enteric Disease Testing and Therapeutic Market Share by Region (2019-2024)
Table 9. Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Enteric Disease Testing and Therapeutic Market Share by Region (2025-2030)
Table 11. Enteric Disease Testing and Therapeutic Market Trends
Table 12. Enteric Disease Testing and Therapeutic Market Drivers
Table 13. Enteric Disease Testing and Therapeutic Market Challenges
Table 14. Enteric Disease Testing and Therapeutic Market Restraints
Table 15. Global Enteric Disease Testing and Therapeutic Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Enteric Disease Testing and Therapeutic Market Share by Players (2019-2024)
Table 17. Global Top Enteric Disease Testing and Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enteric Disease Testing and Therapeutic as of 2023)
Table 18. Ranking of Global Top Enteric Disease Testing and Therapeutic Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Enteric Disease Testing and Therapeutic Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Enteric Disease Testing and Therapeutic Product Solution and Service
Table 22. Date of Enter into Enteric Disease Testing and Therapeutic Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Enteric Disease Testing and Therapeutic Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2019-2024)
Table 26. Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Type (2025-2030)
Table 28. Global Enteric Disease Testing and Therapeutic Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2019-2024)
Table 30. Global Enteric Disease Testing and Therapeutic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Enteric Disease Testing and Therapeutic Revenue Market Share by Application (2025-2030)
Table 32. North America Enteric Disease Testing and Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Enteric Disease Testing and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Enteric Disease Testing and Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Enteric Disease Testing and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Enteric Disease Testing and Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Enteric Disease Testing and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size by Country (2025-2030) & (US$ Million)
Table 47. Abbott Company Detail
Table 48. Abbott Business Overview
Table 49. Abbott Enteric Disease Testing and Therapeutic Product
Table 50. Abbott Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 51. Abbott Recent Development
Table 52. GlaxoSmithKline Company Detail
Table 53. GlaxoSmithKline Business Overview
Table 54. GlaxoSmithKline Enteric Disease Testing and Therapeutic Product
Table 55. GlaxoSmithKline Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 56. GlaxoSmithKline Recent Development
Table 57. Becton Dickinson Company Detail
Table 58. Becton Dickinson Business Overview
Table 59. Becton Dickinson Enteric Disease Testing and Therapeutic Product
Table 60. Becton Dickinson Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 61. Becton Dickinson Recent Development
Table 62. bioMérieux Company Detail
Table 63. bioMérieux Business Overview
Table 64. bioMérieux Enteric Disease Testing and Therapeutic Product
Table 65. bioMérieux Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 66. bioMérieux Recent Development
Table 67. Sanofi Company Detail
Table 68. Sanofi Business Overview
Table 69. Sanofi Enteric Disease Testing and Therapeutic Product
Table 70. Sanofi Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. Bayer Pharma Company Detail
Table 73. Bayer Pharma Business Overview
Table 74. Bayer Pharma Enteric Disease Testing and Therapeutic Product
Table 75. Bayer Pharma Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 76. Bayer Pharma Recent Development
Table 77. Bio-Rad Company Detail
Table 78. Bio-Rad Business Overview
Table 79. Bio-Rad Enteric Disease Testing and Therapeutic Product
Table 80. Bio-Rad Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 81. Bio-Rad Recent Development
Table 82. Quest Diagnostics Company Detail
Table 83. Quest Diagnostics Business Overview
Table 84. Quest Diagnostics Enteric Disease Testing and Therapeutic Product
Table 85. Quest Diagnostics Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 86. Quest Diagnostics Recent Development
Table 87. Trinity Biotech Company Detail
Table 88. Trinity Biotech Business Overview
Table 89. Trinity Biotech Enteric Disease Testing and Therapeutic Product
Table 90. Trinity Biotech Revenue in Enteric Disease Testing and Therapeutic Business (2019-2024) & (US$ Million)
Table 91. Trinity Biotech Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Enteric Disease Testing and Therapeutic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Enteric Disease Testing and Therapeutic Market Share by Type: 2023 VS 2030
Figure 3. Bacterial Disease Features
Figure 4. Viral Disease Features
Figure 5. Parasitic Disease Features
Figure 6. Global Enteric Disease Testing and Therapeutic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Enteric Disease Testing and Therapeutic Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Specialty Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Enteric Disease Testing and Therapeutic Report Years Considered
Figure 12. Global Enteric Disease Testing and Therapeutic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Enteric Disease Testing and Therapeutic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Enteric Disease Testing and Therapeutic Market Share by Region: 2023 VS 2030
Figure 15. Global Enteric Disease Testing and Therapeutic Market Share by Players in 2023
Figure 16. Global Top Enteric Disease Testing and Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enteric Disease Testing and Therapeutic as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Enteric Disease Testing and Therapeutic Revenue in 2023
Figure 18. North America Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Enteric Disease Testing and Therapeutic Market Share by Country (2019-2030)
Figure 20. United States Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Enteric Disease Testing and Therapeutic Market Share by Country (2019-2030)
Figure 24. Germany Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Enteric Disease Testing and Therapeutic Market Share by Region (2019-2030)
Figure 32. China Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Enteric Disease Testing and Therapeutic Market Share by Country (2019-2030)
Figure 40. Mexico Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Enteric Disease Testing and Therapeutic Market Share by Country (2019-2030)
Figure 44. Turkey Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Enteric Disease Testing and Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Abbott Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 47. GlaxoSmithKline Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 48. Becton Dickinson Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 49. bioMérieux Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 50. Sanofi Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 51. Bayer Pharma Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 52. Bio-Rad Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 53. Quest Diagnostics Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 54. Trinity Biotech Revenue Growth Rate in Enteric Disease Testing and Therapeutic Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232